233 related articles for article (PubMed ID: 30312866)
1. Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors.
Lolak N; Akocak S; Bua S; Supuran CT
Bioorg Chem; 2019 Feb; 82():117-122. PubMed ID: 30312866
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
Lolak N; Akocak S; Bua S; Sanku RKK; Supuran CT
Bioorg Med Chem; 2019 Apr; 27(8):1588-1594. PubMed ID: 30846402
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
5. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors.
Ceruso M; Antel S; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(2):205-11. PubMed ID: 25792500
[TBL] [Abstract][Full Text] [Related]
7. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT
Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
Alafeefy AM; Abdel-Aziz HA; Vullo D; Al-Tamimi AM; Awaad AS; Mohamed MA; Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):52-6. PubMed ID: 24666294
[TBL] [Abstract][Full Text] [Related]
10. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
Saluja AK; Tiwari M; Vullo D; Supuran CT
Bioorg Med Chem Lett; 2014 Mar; 24(5):1310-4. PubMed ID: 24507918
[TBL] [Abstract][Full Text] [Related]
11. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors.
Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK
Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of 3-benzenesulfonamide-linked 3-hydrazinoisatin derivatives as carbonic anhydrase inhibitors.
Swain B; Marde VS; Singh P; Angeli A; Khan A; Yaddanapudi VM; Ullah Q; Supuran CT; Arifuddin M
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300718. PubMed ID: 38466120
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors.
Lolak N; Akocak S; Bua S; Koca M; Supuran CT
Bioorg Chem; 2018 Apr; 77():542-547. PubMed ID: 29462772
[TBL] [Abstract][Full Text] [Related]
14. Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors.
Elimam DM; Eldehna WM; Salem R; Bonardi A; Nocentini A; Al-Rashood ST; Elaasser MM; Gratteri P; Supuran CT; Allam HA
Eur J Med Chem; 2022 Jan; 228():114008. PubMed ID: 34871842
[TBL] [Abstract][Full Text] [Related]
15. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.
Eldehna WM; Fares M; Ceruso M; Ghabbour HA; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA; Supuran CT
Eur J Med Chem; 2016 Mar; 110():259-66. PubMed ID: 26840366
[TBL] [Abstract][Full Text] [Related]
16. 4-Substituted benzenesulfonamides featuring cyclic imides moieties exhibit potent and isoform-selective carbonic anhydrase II/IX inhibition.
Abdel-Aziz AA; El-Azab AS; Ghiaty AH; Gratteri P; Supuran CT; Nocentini A
Bioorg Chem; 2019 Mar; 83():198-204. PubMed ID: 30380448
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
[TBL] [Abstract][Full Text] [Related]
18. Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.
Angapelly S; Ramya PVS; Angeli A; Del Prete S; Capasso C; Arifuddin M; Supuran CT
Bioorg Med Chem; 2017 Oct; 25(20):5726-5732. PubMed ID: 28887000
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties.
Ceruso M; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem; 2013 Nov; 21(22):6929-36. PubMed ID: 24103430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
